ArticleProstate cancer and prostatic diseases2021

The effects of new life-prolonging drugs for metastatic castration-resistant prostate cancer (mCRPC) patients in a real-world population.

H M Westgeest et al.PubMed ↗Publisher ↗

No numbers read from the abstract.